EntryPoint Capital’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,919
Closed -$159K 733
2025
Q4
$159K Buy
15,919
+3,142
+25% +$30K 0.06% 584
2025
Q3
$114K Buy
+12,777
New +$118K 0.04% 612
2024
Q2
Sell
-8,109
Closed -$93.3K 846
2024
Q1
$93.3K Sell
8,109
-35,371
-81% -$300K 0.08% 468
2023
Q4
$317K Buy
+43,480
New +$343K 0.3% 19

Other funds holding AHCO

EntryPoint Capital's AHCO Position: Q1 2026 in Review

EntryPoint Capital sold out of AdaptHealth (AHCO) in Q1 2026, closing a stake of 15,919 shares — an estimated $159K sold.

EntryPoint Capital first reported a position in AHCO in Q4 2023 and held it in 4 quarters. The position peaked at $317K in Q4 2023. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • EntryPoint Capital reported no remaining AdaptHealth position as of Q1 2026 after selling out during the quarter.
  • EntryPoint Capital sold 15,919 AdaptHealth shares in Q1 2026, an estimated $159K.
  • EntryPoint Capital first reported a position in AdaptHealth in Q4 2023 and held it in 4 quarters.
  • EntryPoint Capital's AdaptHealth position peaked at $317K in Q4 2023.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on EntryPoint Capital's 13F filing for Q1 2026, filed 14 May 2026.